Evaluation of the cell death markers for aberrated cell free DNA release in high altitude pulmonary edema
Clinical Science · 2024
DOI: 10.1042/cs20242052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2024. Verfasst von Manzoor Ali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Genomics and Genome Biology Unit, CSIR-Institute of Genomics and Integrative Biology, Delhi 110007, India. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Altitude Sickness, Biomarkers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: Council of Scientific and Industrial Research, India (CSIR), Science and Engineering Research Board (SERB).
Abstract (Originalsprache)
The effect of high altitude (HA, altitude >2500 m) can trigger a maladaptive response in unacclimatized individuals, leading to various HA illnesses such as high altitude pulmonary edema (HAPE). The present study investigates circulating cell free (cf) DNA, a minimally invasive biomarker that can elicit a pro-inflammatory response. Our earlier study observed altered cfDNA fragment patterns in HAPE patients and the significant correlation of these patterns with peripheral oxygen saturation levels. However, the unclear release mechanisms of cfDNA in circulation limit its characterization and clinical utility. The present study not only observed a significant increase in cfDNA levels in HAPE patients (27.03 ± 1.37 ng/ml; n = 145) compared to healthy HA sojourners (controls, 14.57 ± 0.74 ng/ml; n = 65) and highlanders (HLs, 15.50 ± 0.8 ng/ml; n = 34) but also assayed the known cell death markers involved in cfDNA release at HA. The study found significantly elevated levels of the apoptotic marker, annexin A5, and secondary necrosis or late apoptotic marker, high mobility group box 1, in HAPE patients. In addition, we observed a higher oxidative DNA damage marker, 8-hydroxy-2′-deoxyguanosine, in HAPE compared with controls, suggestive of the role of oxidative DNA status in promoting the inflammatory potential of cfDNA fragments and their plausible role in manifesting HAPE pathophysiology. Extensive in vitro future assays can confirm the immunogenic role of cfDNA fragments that may act as a danger-associated molecular pattern and associate with markers of cellular stresses in HAPE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genomics and Genome Biology Unit, CSIR-Institute of Genomics and Integrative Biology, Delhi 110007, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
- Department of Medicine, Sonam Norboo Memorial Hospital, Leh 194101, India.
ORCID-Profile: Aastha Mishra
Förderung
- Council of Scientific and Industrial Research, India (CSIR)
- Science and Engineering Research Board (SERB)
Zitieren
APA
Ali, M., Kumar, K. G., Singh, K., Rabyang, S., Thinlas, T., & Mishra, A. (2024). Evaluation of the cell death markers for aberrated cell free DNA release in high altitude pulmonary edema. Clinical Science. https://doi.org/10.1042/cs20242052
Vancouver
Ali M, Kumar KG, Singh K, Rabyang S, Thinlas T, Mishra A. Evaluation of the cell death markers for aberrated cell free DNA release in high altitude pulmonary edema. Clinical Science. 2024. doi:10.1042/cs20242052
BibTeX
@article{Ali2024,
author = {Ali, Manzoor and Kumar, Krishna G and Singh, Kanika and Rabyang, Stanzen and Thinlas, Tashi and Mishra, Aastha},
title = {Evaluation of the cell death markers for aberrated cell free DNA release in high altitude pulmonary edema},
journal = {Clinical Science},
year = {2024},
doi = {10.1042/cs20242052}
}
EUVIMED